USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Jeisys Medical Inc.

USPTO PatentsView assignee record - 19 granted patents across 6 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

19
Total patents granted
6
CPC technology areas
11.2
Avg claims per patent
-
5-year filing velocity

The verdict

Jeisys holds 19 US patents across 6 technology areas, rank #15,394 of 50,000 tracked assignees.

#15,394
of 50,000 US assignees by volume
Top 23%
by Innovation Score (45.7/100)
11.2
avg claims per patent

Portfolio overview

Jeisys Medical Inc. has been granted 19 US utility patents between 2021 and 2025, placing Jeisys Medical Inc. at rank #15,394 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.2 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a Foreign Corporation, Jeisys Medical Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 45.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 19 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Jeisys Medical Inc.'s 11.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Jeisys Medical Inc. against peers pursuing similar technology classes.

How does Jeisys compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Jeisys holds 19 patents, placing it at rank #15,394 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Jeisys's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

46 Top 23% higher than 77% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

02468 20212022202320242025 3
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Jeisys Medical Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 2 10.5%
2022 4 21.1%
2023 3 15.8%
2024 7 36.8%
2025 3 15.8%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple

Where it ranks

Overall rank by patents

#15,394

Across all tracked assignees

Innovation Score

45.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Jeisys Medical Inc. hold?
Jeisys Medical Inc. holds 19 US granted patents filed between 2021 and 2025, spanning 6 technology areas.
What is Jeisys Medical Inc.'s Innovation Score?
Jeisys Medical Inc. has an Innovation Score of 45.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Jeisys Medical Inc. focus on?
Jeisys Medical Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 16 patents. The company has filed patents in 6 CPC subclasses total.
Is Jeisys Medical Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Jeisys Medical Inc..
What does claim depth mean for Jeisys Medical Inc.'s patents?
Jeisys Medical Inc.'s patents average 11.2 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Jeisys Medical Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Jeisys's 19 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Jeisys ranks #15,394 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov